Where the stock stands
Aster DM Quality Care Ltd. is a Healthcare-sector listing. As of 5 August 2026 the stock closed at Rs 842.1, up 0.89% from the previous close of Rs 834.7. The wider market barely moved that day — the Nifty was up 0.04% — so the gain was specific to the stock rather than an index effect. Market capitalisation stood at Rs 73,404 crore.
The close is 1.71% below the 52-week high of Rs 856.75 and 62.22% above the 52-week low of Rs 519.1. Trailing returns are positive across every window the pack measures — up 2.9% over a week, 6.7% over a month, 13.4% over three months and 39.2% over a year. On valuation the pack reports a price-to-earnings ratio of 113.49 against earnings per share of Rs 7.42, a price-to-book of 9.48, return on equity of 10.1% and a dividend yield of 0.48%.
What the smart-money flow shows
The most honest thing to report here is an absence. This evidence pack contains no derivatives data for the stock — no open-interest change, no long buildup (fresh futures positions opened while the price rises) or short buildup — and it records no named bulk or block deals, no institutional buying or selling streak, and no insider filings. Those channels are not covered, so nothing can be said about them either way.
What the pack does carry is a dense run of six exchange filings, all within the last month. On 5 August the company informed the exchange about the acquisition of equity shares of United CIIGMA Institute of Medical Sciences, which the filing calls a subsidiary. On 13, 14 and 15 July, three separate filings covered the allotment of equity shares to shareholders of the transferor company, QCIL, under a scheme of amalgamation. A 4 July filing pointed to a press release on completion of the merger between Aster DM Healthcare and Quality Care India Limited. Also on 4 July came a filing about the resignation of a director or key managerial person, which Strota's screen tags with a bearish lean; no name, role or reason is given.
The one quantitative trace of participation is relative volume at 2.25, meaning the session traded at over twice the stock's own recent normal. Turnover was heavy; the pack does not identify who was transacting.
The technical picture
The stock trades above both its 50-day and its 200-day moving average, placing it on the constructive side of the two most-watched trend lines. Neither a golden cross nor a death cross — the 50-day average crossing the 200-day — is flagged.
The 14-day RSI, a momentum gauge that rises as gains accumulate, reads 64.9, which the pack does not mark as an extreme either way. Together with a close 1.71% off the 52-week high, the record describes a stock in an established uptrend near the top of its range on above-average turnover. That is the state, not the next move.
Catalysts and what to watch
The freshest item is a report from NDTV Profit headlined that Aster DM's Q1 profit plummeted 81% as a one-time loss weighed, with revenue crossing Rs 1,300 crore. That is a headline, not a figure verified by any filing in this pack, and no other detail on the quarter appears. Separately, a report from Moneycontrol.com about a month earlier framed the Aster-Quality Care merger as a bet on India's smaller cities. The rest are routine live-price pages from ICICI Direct, CNBC TV18, The Economic Times and scanx.trade — coverage rather than news.
What the data establishes is narrow but real: a merger-related filing cluster, a stock near its 52-week high after a year of gains, a high multiple against a modest return on equity, and heavy volume in the latest session. What it does not establish is causation, institutional intent, or how the reported profit fall sits alongside the merger accounting.